Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/dragonfly-has-received-milestone-payment-following-dosing-of-first-patient-in-abbvie-phase-1-clinical-trial-evaluating-df4101abbv-303-302078944.html
https://www.prnewswire.com/news-releases/dragonfly-announces-clinical-collaboration-exploring-combinations-of-dragonflys-df1001-her-2-trinket-with-gileads-trodelvy-in-two-cancer-indications-302062613.html
https://www.prnewswire.com/news-releases/dragonfly-therapeutics-initiates-phase-11b-study-of-its-il-2-immunotherapy-in-patients-with-advanced-solid-tumors-302006150.html
https://www.prnewswire.com/news-releases/dragonfly-therapeutics-announces-the-presentation-of-phase-1-df1001-trinket-dose-escalation-results-at-asco-2023-annual-meeting-301842406.html
https://www.prnewswire.com/news-releases/dragonfly-therapeutics-to-present-phase-1-df1001-monotherapy-dose-escalation-results-at-asco-2023-annual-meeting-301840855.html
https://www.contractpharma.com/contents/view_breaking-news/2023-06-02/dragonfly-therapeutics-expands-clinical-leadership/?widget=listSection
https://www.prnewswire.com/news-releases/dragonfly-therapeutics-announces-the-publication-of-preclinical-data-supporting-df6002-its-extended-half-life-il-12-cytokine-as-a-promising-treatment-for-cancer-301798329.html
https://www.fiercebiotech.com/biotech/bms-returns-475m-oncology-asset-back-dragonflys-pond
https://www.contractpharma.com/contents/view_breaking-news/2023-02-02/dragonfly-therapeutics-appoints-joseph-eid-as-president-of-research-development/?widget=listSection
https://www.prnewswire.com/news-releases/dr-joseph-e-eid-who-led-mercks-pioneering-clinical-development-of-keytruda-joins-dragonfly-therapeutics-as-president-of-rd-301736277.html